Xiaofen Mo
- Ophthalmology top 5%
- Retinal Diseases and Treatments 5
- Glaucoma and retinal disorders 3
- Pharmaceutical Science top 5%
-
- Nerve injury and regeneration 5
- Neuroscience and Neural Engineering 3
- Bioengineering top 10%
-
- Retinal Development and Disorders 6
-
- Ophthalmology and Visual Impairment Studies 3
-
- Corneal surgery and disorders 3
-
- Ocular Surface and Contact Lens 3
- Co-authors
- Kenneth L. RockAlfred L. GoldbergIan A. YorkXianfang RongPaolo CascioToshiyuki OshitariMari DezawaHuamao Miao
- Journals
- Journal of Ocular Pharmacology and Therapeutics (2 papers)International Journal of Nanomedicine (2 papers)Investigative Ophthalmology & Visual Science (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Xiaofen Mo
33 papers receiving 976 citations
Peers
Comparison fields: 5 of 98
- Ophthalmology 178
- Immunology 215
- Pharmaceutical Science 57
- Cellular and Molecular Neuroscience 167
- Bioengineering 47
Countries citing papers authored by Xiaofen Mo
This map shows the geographic impact of Xiaofen Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofen Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofen Mo more than expected).
Fields of papers citing papers by Xiaofen Mo
This network shows the impact of papers produced by Xiaofen Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofen Mo. The network helps show where Xiaofen Mo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaofen Mo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 1 | |
| 7 | 2018 | 58 | |
| 8 | 2015 | 14 | |
| 9 | 2014 | 31 | |
| 10 | 2013 | 1 | |
| 11 | [Ginkgolide B promotes axonal growth of retina ganglion cells by anti-apoptosis in vitro]. | 2012 | 8 |
| 12 | 2012 | 4 | |
| 13 | 2012 | 74 | |
| 14 | 2011 | 47 | |
| 15 | 2010 | 17 | |
| 16 | 2009 | 24 | |
| 17 | 2002 | 72 | |
| 18 | 2001 | 9 | |
| 19 | 1999 | 121 | |
| 20 | 1999 | 190 |
About Xiaofen Mo
Xiaofen Mo is a scholar working on Ophthalmology, Developmental Neuroscience, Cellular and Molecular Neuroscience, Neurology and Molecular Medicine, having authored 34 papers that have together received 999 indexed citations. Recurring topics across this work include Retinal Development and Disorders (6 papers), Retinal Diseases and Treatments (5 papers), Nerve injury and regeneration (5 papers), Glaucoma and retinal disorders (3 papers), Neuroscience and Neural Engineering (3 papers), Ophthalmology and Visual Impairment Studies (3 papers), Corneal surgery and disorders (3 papers) and Ocular Surface and Contact Lens (3 papers). The work is most often cited by research in Ophthalmology (178 citations), Immunology (215 citations), Pharmaceutical Science (57 citations), Cellular and Molecular Neuroscience (167 citations) and Bioengineering (47 citations). Xiaofen Mo has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Kenneth L. Rock, Alfred L. Goldberg, Ian A. York, Xianfang Rong, Paolo Cascio, Toshiyuki Oshitari, Mari Dezawa, Huamao Miao, Leilei Gu and Gang Chen. Their work appears in journals such as Journal of Ocular Pharmacology and Therapeutics, International Journal of Nanomedicine, Investigative Ophthalmology & Visual Science, Journal of Neuroscience and Current Eye Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.